We are excited to share that our lab has received an ERC Consolidator Grant for the project UnlockIT: Unleashing T cell-mediated Immune response in therapy-challenged Tumours’
The grant will strengthen the lab’s efforts in investigating the tumour – tumour microenvironment coevolution during targeted therapy, specifically KRAS inhibitor treatment, and the related mechanisms of drug resistance.
You can read more on the IMP website here.